Readoutin 104d
Beijing Suncadia Pharmaceuticals Co., Ltd — SHR-1918/ SHR-1918 placebo
Phase 3 primary completion: A Study of SHR-1918 In Participants With Hypertriglyceridemia.
- Date
- Mar 2027
- Type
- Readout
- Indication
- Hypertriglyceridemia
Readoutin 104d
Phase 3 primary completion: A Study of SHR-1918 In Participants With Hypertriglyceridemia.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.